Materias dentro de su búsqueda.
Mostrando 4,861 - 4,871 Resultados de 4,871 Para Buscar '"Belgium"', tiempo de consulta: 0.20s Limitar resultados
  1. 4861
    por Declercq, Jozefien, Van Damme, Karel F A, De Leeuw, Elisabeth, Maes, Bastiaan, Bosteels, Cedric, Tavernier, Simon J, De Buyser, Stefanie, Colman, Roos, Hites, Maya, Verschelden, Gil, Fivez, Tom, Moerman, Filip, Demedts, Ingel K, Dauby, Nicolas, De Schryver, Nicolas, Govaerts, Elke, Vandecasteele, Stefaan J, Van Laethem, Johan, Anguille, Sebastien, van der Hilst, Jeroen, Misset, Benoit, Slabbynck, Hans, Wittebole, Xavier, Liénart, Fabienne, Legrand, Catherine, Buyse, Marc, Stevens, Dieter, Bauters, Fre, Seys, Leen J M, Aegerter, Helena, Smole, Ursula, Bosteels, Victor, Hoste, Levi, Naesens, Leslie, Haerynck, Filomeen, Vandekerckhove, Linos, Depuydt, Pieter, van Braeckel, Eva, Rottey, Sylvie, Peene, Isabelle, Van Der Straeten, Catherine, Hulstaert, Frank, Lambrecht, Bart N
    Publicado 2021
    “…METHODS: We did a prospective, multicentre, open-label, randomised, controlled trial, in hospitalised patients with COVID-19, hypoxia, and signs of a cytokine release syndrome across 16 hospitals in Belgium. Eligible patients had a proven diagnosis of COVID-19 with symptoms between 6 and 16 days, a ratio of the partial pressure of oxygen to the fraction of inspired oxygen (PaO(2):FiO(2)) of less than 350 mm Hg on room air or less than 280 mm Hg on supplemental oxygen, and signs of a cytokine release syndrome in their serum (either a single ferritin measurement of more than 2000 μg/L and immediately requiring high flow oxygen or mechanical ventilation, or a ferritin concentration of more than 1000 μg/L, which had been increasing over the previous 24 h, or lymphopenia below 800/mL with two of the following criteria: an increasing ferritin concentration of more than 700 μg/L, an increasing lactate dehydrogenase concentration of more than 300 international units per L, an increasing C-reactive protein concentration of more than 70 mg/L, or an increasing D-dimers concentration of more than 1000 ng/mL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
  2. 4862
    por Pinato, David J, Tabernero, Josep, Bower, Mark, Scotti, Lorenza, Patel, Meera, Colomba, Emeline, Dolly, Saoirse, Loizidou, Angela, Chester, John, Mukherjee, Uma, Zambelli, Alberto, Dalla Pria, Alessia, Aguilar-Company, Juan, Ottaviani, Diego, Chowdhury, Amani, Merry, Eve, Salazar, Ramon, Bertuzzi, Alexia, Brunet, Joan, Lambertini, Matteo, Tagliamento, Marco, Pous, Anna, Sita-Lumsden, Ailsa, Srikandarajah, Krishnie, Colomba, Johann, Pommeret, Fanny, Seguí, Elia, Generali, Daniele, Grisanti, Salvatore, Pedrazzoli, Paolo, Rizzo, Gianpiero, Libertini, Michela, Moss, Charlotte, Evans, Joanne S, Russell, Beth, Harbeck, Nadia, Vincenzi, Bruno, Biello, Federica, Bertulli, Rossella, Liñan, Raquel, Rossi, Sabrina, Carmona-García, Maria Carmen, Tondini, Carlo, Fox, Laura, Baggi, Alice, Fotia, Vittoria, Parisi, Alessandro, Porzio, Giampero, Saponara, Maristella, Cruz, Claudia Andrea, García-Illescas, David, Felip, Eudald, Roqué Lloveras, Ariadna, Sharkey, Rachel, Roldán, Elisa, Reyes, Roxana, Earnshaw, Irina, Ferrante, Daniela, Marco-Hernández, Javier, Ruiz-Camps, Isabel, Gaidano, Gianluca, Patriarca, Andrea, Bruna, Riccardo, Sureda, Anna, Martinez-Vila, Clara, Sanchez de Torre, Ana, Cantini, Luca, Filetti, Marco, Rimassa, Lorenza, Chiudinelli, Lorenzo, Franchi, Michela, Krengli, Marco, Santoro, Armando, Prat, Aleix, Van Hemelrijck, Mieke, Diamantis, Nikolaos, Newsom-Davis, Thomas, Gennari, Alessandra, Cortellini, Alessio
    Publicado 2021
    “…For this retrospective study, patients were enrolled from 35 institutions across Belgium, France, Germany, Italy, Spain, and the UK. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
  3. 4863
    “…International surveys in European countries such as France, Italy, Belgium, the Netherlands, Portugal, or the Czech Republic reported a (hypothetical) willingness to vaccinate among university students between 58 and 86% for COVID-19 vaccination, indicating that relevant proportions among the students were hesitant whether to get vaccinated against COVID-19 or not. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Informiert = Geimpft? Das Informationsverhalten und die COVID-19-Impfentscheidung bei Studierenden
  4. 4864
    por Cortellini, Alessio, Tabernero, Josep, Mukherjee, Uma, Salazar, Ramon, Sureda, Anna, Maluquer, Clara, Ferrante, Daniela, Bower, Mark, Sharkey, Rachel, Mirallas, Oriol, Plaja, Andrea, Cucurull, Marc, Mesia, Ricard, Dalla Pria, Alessia, Newsom-Davis, Thomas, Van Hemelrijck, Mieke, Sita-Lumsden, Ailsa, Apthorp, Eleanor, Vincenzi, Bruno, Di Fazio, Giuseppina Rita, Tonini, Giuseppe, Pantano, Francesco, Bertuzzi, Alexia, Rossi, Sabrina, Brunet, Joan, Lambertini, Matteo, Pedrazzoli, Paolo, Biello, Federica, D'Avanzo, Francesca, Lee, Alvin J X, Shawe-Taylor, Marianne, Rogers, Lucy, Murphy, Cian, Cooper, Lee, Andaleeb, Ramis, Khalique, Saira, Bawany, Samira, Ahmed, Sarah, Carmona-García, M Carmen, Fort-Culillas, Roser, Liñan, Raquel, Zoratto, Federica, Rizzo, Gianpiero, Perachino, Marta, Doonga, Kris, Gaidano, Gianluca, Bruna, Riccardo, Patriarca, Andrea, Martinez-Vila, Clara, Pérez Criado, Ignacio, Giusti, Raffaele, Mazzoni, Francesca, Antonuzzo, Lorenzo, Santoro, Armando, Parisi, Alessandro, Queirolo, Paola, Aujayeb, Avinash, Rimassa, Lorenza, Diamantis, Nikolaos, Bertulli, Rossella, Fulgenzi, Claudia A M, D'Alessio, Antonio, Ruiz-Camps, Isabel, Saoudi-Gonzalez, Nadia, Garcia Illescas, David, Medina, Irene, Fox, Laura, Gennari, Alessandra, Aguilar-Company, Juan, Pinato, David J
    Publicado 2023
    “…METHODS: OnCovid is an active registry that includes patients aged 18 years or older from 37 institutions across Belgium, France, Germany, Italy, Spain, and the UK with a laboratory-confirmed diagnosis of COVID-19 and a history of solid or haematological malignancy, either active or in remission, followed up from COVID-19 diagnosis until death. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
  5. 4865
    Publicado 2012
    “…In an animal study, Ampligen® was shown to prevent destruction of nerve cells, reduce virus concentrations in the brain and blood stream and increase survival rates.[6] Researchers at the Rega Institute in Belgium have published results from an animal study demonstrating that Ampligen® was superior at protecting mice against coxsackie B3 virus-induced myocarditis compared with pegylated interferon.[7] In May 2004 Hemispherx announced that it had filed an expanded US patent application covering the use of Ampligen® for the potential treatment and prevention of severe acute respiratory syndrome (SARS) and dreaded emerging viruses.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mismatched Double-Stranded RNA: PolyI:PolyC12U
  6. 4866
    “…STUDY DESIGN, SIZE, DURATION: This multicentre, open-label randomized controlled superiority trial was carried out in 10 hospitals in the Netherlands and 1 hospital in Belgium between January 2014 and December 2018. We randomly assigned women with breast cancer, aged 18–43 years, who opted for banking of oocytes or embryos to one of three study arms; ovarian stimulation plus tamoxifen, ovarian stimulation plus letrozole or standard ovarian stimulation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols
  7. 4867
    por Velasco, Pablo, Longo, Filomena, Piolatto, Andrea, Bardón-Cancho, Eduardo J., Ponce-Salas, Beatriz, Flevari, Pagona, Voskaridou, Ersi, Biemond, Bart J., Nur, Erfan, Delaporta, Polyxeni, Besse-Hammer, Tatiana, Ruiz-Llobet, Anna, Raso, Simona, Spasiano, Anna, Guerzoni, Maria Elena, Beneitez-Pastor, David, Dedeken, Laurence, Pepe, Alessia, Rosso, Rosamaria, Kunz, Joachim B., de Montalembert, Mariane, Campisi, Saveria, Glenthøj, Andreas, Gonzalez Urdiales, Paula, Benghiat, Fleur Samantha, Azerad, Marie-Agnès, Saunders, Christopher J., Ferreira Faria, Teresa, Casini, Tommaso, Bagnato, Sabrina, Van de Velde, Ann, Labarque, Veerle, Bertoni, Elisa, Van Damme, An, Diamantidis, Michael D., Russo, Roberta, Stiakaki, Eftichia, Quota, Alessandra, Christou, Soteroula, Teles, Maria Jose, Lafiatis, Ioannis, Kerkhoffs, Jean-Louis, Argüello Marina, María, Lorite, Mikael, Rodriguez, Alexis, Iolascon, Achille, Taher, Ali T., Colombatti, Raffaella, Roy, Noemi, Mañú Pereira, Maria Del Mar
    Publicado 2021
    “…Results As of June 2021, 42 medical centers from 10 EU countries had registered 373 patients: 191 Sickle cell disease (SCD), 156 Thalassemia major and intermedia (THAL) and 26 other RBCD. 84% of the SCD patients were reported by Spain, Belgium, Italy and The Netherlands and 92% of the THAL patients by Italy and Greece. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19
  8. 4868
    por Crous, P.W., Osieck, E.R., Jurjević, Ž., Boers, J., van Iperen, A.L., Starink-Willemse, M., Dima, B., Balashov, S., Bulgakov, T.S., Johnston, P.R., Morozova, O.V., Pinruan, U., Sommai, S., Alvarado, P., Decock, C.A., Lebel, T., McMullan-Fisher, S., Moreno, G., Shivas, R.G., Zhao, L., Abdollahzadeh, J., Abrinbana, M., Ageev, D.V., Akhmetova, G., Alexandrova, A.V., Altés, A., Amaral, A.G.G., Angelini, C., Antonín, V., Arenas, F., Asselman, P., Badali, F., Baghela, A., Bañares, A., Barreto, R.W., Baseia, I.G., Bellanger, J.-M., Berraf-Tebbal, A., Biketova, A.Yu., Bukharova, N.V., Burgess, T.I., Cabero, J., Câmara, M.P.S., Cano-Lira, J.F., Ceryngier, P., Chávez, R., Cowan, D.A., de Lima, A.F., Oliveira, R.L., Denman, S., Dang, Q.N., Dovana, F., Duarte, I.G., Eichmeier, A., Erhard, A., Esteve-Raventós, F., Fellin, A., Ferisin, G., Ferreira, R.J., Ferrer, A., Finy, P., Gaya, E., Geering, A.D.W., Gil-Durán, C., Glässnerová, K., Glushakova, A.M., Gramaje, D., Guard, F.E., Guarnizo, A.L., Haelewaters, D., Halling, R.E., Hill, R., Hirooka, Y., Hubka, V., Iliushin, V.A., Ivanova, D.D., Ivanushkina, N.E., Jangsantear, P., Justo, A., Kachalkin, A.V., Kato, S., Khamsuntorn, P., Kirtsideli, I.Y., Knapp, D.G., Kochkina, G.A., Koukol, O., Kovács, G.M., Kruse, J., Kumar, T.K.A., Kušan, I., Læssøe, T., Larsson, E., Lebeuf, R., Levicán, G., Loizides, M., Marinho, P., Luangsa-ard, J.J., Lukina, E.G., Magaña-Dueñas, V., Maggs-Kölling, G., Malysheva, E.F., Malysheva, V.F., Martín, B., Martín, M.P., Matočec, N., McTaggart, A.R., Mehrabi-Koushki, M., Mešić, A., Miller, A.N., Mironova, P., Moreau, P.-A., Morte, A., Müller, K., Nagy, L.G., Nanu, S., Navarro-Ródenas, A., Nel, W.J., Nguyen, T.H., Nóbrega, T.F., Noordeloos, M.E., Olariaga, I., Overton, B.E., Ozerskaya, S.M., Palani, P., Pancorbo, F., Papp, V., Pawłowska, J., Pham, T.Q., Phosri, C., Popov, E.S., Portugal, A., Pošta, A., Reschke, K., Reul, M., Ricci, G.M., Rodríguez, A., Romanowski, J., Ruchikachorn, N., Saar, I., Safi, A., Sakolrak, B., Salzmann, F., Sandoval-Denis, M., Sangwichein, E., Sanhueza, L., Sato, T., Sastoque, A., Senn-Irlet, B., Shibata, A., Siepe, K., Somrithipol, S., Spetik, M., Sridhar, P., Stchigel, A.M., Stuskova, K., Suwannasai, N., Tan, Y.P., Thangavel, R., Tiago, I., Tiwari, S., Tkalčec, Z., Tomashevskaya, M.A., Tonegawa, C., Tran, H.X., Tran, N.T., Trovão, J., Trubitsyn, V.E., Van Wyk, J., Vieira, W.A.S., Vila, J., Visagie, C.M., Vizzini, A., Volobuev, S.V., Vu, D.T., Wangsawat, N., Yaguchi, T., Ercole, E., Ferreira, B.W., de Souza, A.P., Vieira, B.S., Groenewald, J.Z.
    Publicado 2021
    “…Australia, Austroboletus yourkae on soil, Crepidotus innuopurpureus on dead wood, Curvularia stenotaphri from roots and leaves of Stenotaphrum secundatum and Thecaphora stajsicii from capsules of Oxalis radicosa. Belgium, Paraxerochrysium coryli (incl. Paraxerochrysium gen. nov.) from Corylus avellana. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Fungal Planet description sheets: 1284–1382
  9. 4869
    “…METHODS: This phase 2, open-label, non-comparative study enrolled patients at 10 centers in Belgium, Spain, and the US between 2019 and 2022. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1699. Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients
  10. 4870
    “…Participants will be recruited from approximately 30 clinical centres in Belgium, France, the UK, USA and Brazil. Maximum patients’ participation in the study will last 28 days. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial
  11. 4871
    “…METHODS: 8,643 organisms were consecutively collected (1/patient) from 74 medical centers located in the US (n=4,544; 33 centers), western EU (W-EU; n=3,330; 28 centers from 10 nations: Belgium, France, Germany, Ireland, Italy, Portugal, Spain, Sweden, Switzerland, and the United Kingdom), and eastern EU (E-EU; n=769; 13 centers from 10 nations: Belarus, Czech Republic, Greece, Hungary, Israel, Poland, Romania, Russia, Slovenia, and Turkey). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    217. Antimicrobial Activity of Dalbavancin against Gram-Positive Bacteria Isolated from Patients Hospitalized with Bacteremia in United States and European Medical Centers: Results from the International Dalbavancin Evaluation of Activity (IDEA) Program (2018-202)
Herramientas de búsqueda: RSS